352 related articles for article (PubMed ID: 33413202)
21. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
22. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
23. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
24. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.
Rosenblatt AE; Garcia MI; Lyons L; Xie Y; Maiorino C; Désiré L; Slingerland J; Burnstein KL
Endocr Relat Cancer; 2011 Apr; 18(2):207-19. PubMed ID: 21118977
[TBL] [Abstract][Full Text] [Related]
26. 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
Pang X; Zhang L; Lai L; Chen J; Wu Y; Yi Z; Zhang J; Qu W; Aggarwal BB; Liu M
Carcinogenesis; 2011 Jun; 32(6):904-12. PubMed ID: 21427164
[TBL] [Abstract][Full Text] [Related]
27. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.
Wang G; Beier F
J Bone Miner Res; 2005 Jun; 20(6):1022-31. PubMed ID: 15883643
[TBL] [Abstract][Full Text] [Related]
28. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
29. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.
Schlegel N; Meir M; Spindler V; Germer CT; Waschke J
J Cell Physiol; 2011 May; 226(5):1196-203. PubMed ID: 20945370
[TBL] [Abstract][Full Text] [Related]
30. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
Zhu Z; Yu Z; Rong Z; Luo Z; Zhang J; Qiu Z; Huang C
Theranostics; 2019; 9(26):8294-8311. PubMed ID: 31754397
[No Abstract] [Full Text] [Related]
31. Small rho GTPases mediate tumor-induced inhibition of endocytic activity of dendritic cells.
Tourkova IL; Shurin GV; Wei S; Shurin MR
J Immunol; 2007 Jun; 178(12):7787-93. PubMed ID: 17548616
[TBL] [Abstract][Full Text] [Related]
32. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
33. Cdc42 Mediates Cancer Cell Chemotaxis in Perineural Invasion.
Chernichenko N; Omelchenko T; Deborde S; Bakst RL; He S; Chen CH; Gusain L; Vakiani E; Katabi N; Hall A; Wong RJ
Mol Cancer Res; 2020 Jun; 18(6):913-925. PubMed ID: 32086369
[TBL] [Abstract][Full Text] [Related]
34. The rho guanosine 5'-triphosphatase, cell division cycle 42, is required for insulin-induced actin remodeling and glucagon-like peptide-1 secretion in the intestinal endocrine L cell.
Lim GE; Xu M; Sun J; Jin T; Brubaker PL
Endocrinology; 2009 Dec; 150(12):5249-61. PubMed ID: 19819966
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
36. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells.
Ge J; Burnier L; Adamopoulou M; Kwa MQ; Schaks M; Rottner K; Brakebusch C
J Biol Chem; 2018 Jun; 293(24):9358-9369. PubMed ID: 29700112
[TBL] [Abstract][Full Text] [Related]
37. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.
Liu Y; Dou Y; Yan L; Yang X; He B; Kong L; Smith W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578854
[TBL] [Abstract][Full Text] [Related]
38. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
Leng R; Liao G; Wang H; Kuang J; Tang L
Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
[TBL] [Abstract][Full Text] [Related]
39. Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.
Wan Q; Cho E; Yokota H; Na S
Biochem Biophys Res Commun; 2013 Apr; 433(4):502-7. PubMed ID: 23524265
[TBL] [Abstract][Full Text] [Related]
40. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]